A comparison of case-finding strategies in the UK for the management of hip fractures. (Q51453264)

5 April 2018

title

A comparison of case-finding strategies in the UK for the management of hip fractures. (English)

1 reference

5 April 2018

author name string

H Johansson

1

1 reference

5 April 2018

J A Kanis

2

1 reference

5 April 2018

A Oden

3

1 reference

5 April 2018

J Compston

4

1 reference

5 April 2018

E McCloskey

5

1 reference

5 April 2018

language of work or name

English

0 references

publication date

11 January 2012

1 reference

5 April 2018

Osteoporosis International

published in

1 reference

5 April 2018

volume

23

1 reference

5 April 2018

issue

3

1 reference

5 April 2018

page(s)

907-915

1 reference

5 April 2018

https://scigraph.springernature.com/pub.10.1007/s00198-011-1864-y

exact match

0 references

cites work

Guidelines for diagnosis and management of osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

Comparison of the European and USA Practice Guidelines for Osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

An assessment tool for predicting fracture risk in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

Diagnosis of osteoporosis and assessment of fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

BMD, clinical risk factors and their combination for hip fracture prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

FRAX and the assessment of fracture probability in men and women from the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

Updated data on proximal femur bone mineral levels of US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

The burden of osteoporotic fractures: a method for setting intervention thresholds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

A revised clinician's guide to the prevention and treatment of osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1864-Y

National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist

21 January 2018

1 reference

12 December 2020

The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach

1 reference

12 December 2020

Monitoring bone mineral density during antiresorptive treatment for osteoporosis

1 reference

12 December 2020

A FRAX® model for the assessment of fracture probability in Belgium.

1 reference

12 December 2020

Optimization of BMD measurements to identify high risk groups for treatment--a test analysis

1 reference

12 December 2020

Intervention thresholds for osteoporosis in the UK

1 reference

12 December 2020

Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies

1 reference

12 December 2020

High fracture probability with FRAX® usually indicates densitometric osteoporosis: implications for clinical practice

1 reference

12 December 2020

10.1007/S00198-011-1864-Y

Identifiers

DOI

1 reference

5 April 2018

release_wbp3h5dumnfnhgvyaz644buifa

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wbp3h5dumnfnhgvyaz644buifa

24 November 2022

mapped directly with Wikidata item

PubMed ID

22234810

1 reference

5 April 2018